We are live on ! Find out more
CRHM

CRH Medical Corporation
CRHM

Delisted

CRHM was delisted on the 22nd of April, 2021.

44 hedge funds and large institutions have $63.8M invested in CRH Medical Corporation in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 19 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more capital invested

Capital invested by funds: $46.5M → $63.8M (+$17.3M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less funds holding

Funds holding: 4544 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

42% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 19

Holders
44
Holders Change
-1
Holders Change %
-2.22%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
11
Reduced
19
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$14.2M
BGC
2
Beutel, Goodman & Co
Ontario, Canada
$8.24M -$557K -275,720 -6%
PRCP
3
Pacific Ridge Capital Partners
Oregon
$6.43M +$784K +388,070 +14%
Connor, Clark & Lunn Investment Management (CC&L)
4
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$4.39M +$32.1K +15,900 +0.8%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$4.34M
Stifel Financial
6
Stifel Financial
Missouri
$4.32M +$201K +99,440 +5%
SCM
7
Stadium Capital Management
Connecticut
$4.01M -$3.22M -1,595,622 -45%
Goldman Sachs
8
Goldman Sachs
New York
$3.26M
Morgan Stanley
9
Morgan Stanley
New York
$2.9M -$3.07M -1,518,000 -52%
Renaissance Technologies
10
Renaissance Technologies
New York
$2.5M -$704K -348,500 -22%
JP Morgan Chase
11
JP Morgan Chase
New York
$2.11M -$88.3K -43,700 -4%
Acadian Asset Management
12
Acadian Asset Management
Massachusetts
$1.49M -$113K -56,110 -7%
2L
13
22NW LP
Washington
$1.41M
RA
14
Royce & Associates
New York
$994K
PP
15
Palladium Partners
Virginia
$774K +$50.5K +25,000 +7%
PPW
16
Parcion Private Wealth
Washington
$467K -$60.6K -30,000 -13%
CAM
17
Claret Asset Management
Quebec, Canada
$385K +$31K +15,331 +9%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$281K -$117K -57,700 -30%
OSAM
19
O'Shaughnessy Asset Management
Connecticut
$221K -$7.74K -3,830 -3%
SCP
20
Seizert Capital Partners
Michigan
$209K +$204K +100,898 New
Arrowstreet Capital
21
Arrowstreet Capital
Massachusetts
$169K +$32.8K +16,213 +25%
WCM
22
Wedge Capital Management
North Carolina
$122K -$7.07K -3,496 -6%
WSTAM
23
Wilbanks Smith & Thomas Asset Management
Virginia
$72K
BNP Paribas Financial Markets
24
BNP Paribas Financial Markets
France
$69.9K +$68.3K +33,783 New
RWM
25
Ritholtz Wealth Management
New York
$63K +$61.5K +30,420 New

CRHM Hedge Fund Activity: Q2 2020 in Review

44 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in CRH Medical Corporation (CRHM) for Q2 2020, worth a combined $63.8M — up 37% from $46.5M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CRHM and 5 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 11 added.

The largest buyer was Pacific Ridge Capital Partners, adding an estimated $784K. The largest seller was Stadium Capital Management, cutting an estimated $3.22M.

  • 44 institutional investors held CRH Medical Corporation (CRHM) as of Q2 2020, down from 45 in Q1 2020.
  • Funds reported $63.8M of CRH Medical Corporation stock for Q2 2020, up 37% quarter-over-quarter.
  • 5 funds opened new CRH Medical Corporation positions in Q2 2020 and 6 closed out, a net change of -1 holder.
  • The largest CRH Medical Corporation buyer in Q2 2020 was Pacific Ridge Capital Partners, an estimated $784K added.
  • The largest CRH Medical Corporation seller in Q2 2020 was Stadium Capital Management, an estimated $3.22M sold.

Based on aggregated 13F filings for Q2 2020.